Skip to content
  • Tuesday, 27 October 2026
  • 9:41 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Novo Nordisk Launches Oral Ozempic in the US, Revolutionizing Type 2 Diabetes and Cardiovascular Risk Management
Pharmaceutical R&D

Novo Nordisk Launches Oral Ozempic in the US, Revolutionizing Type 2 Diabetes and Cardiovascular Risk Management

Teuku Ryan May 4, 2026 0

The landscape of type 2 diabetes management and cardiovascular risk reduction in the United States has been significantly reshaped with…

Read More
Pharmaceutical R&D

Amazon Web Services Launches AI Drug Discovery Platform to Accelerate Novel Therapy Development

Teuku Ryan Apr 16, 2026 0

Amazon Web Services (AWS) has unveiled a groundbreaking artificial intelligence (AI) application designed to significantly accelerate the design and testing…

Read More
Biotech & Genetic Research

Biotech Sector Surges with Strategic Collaborations, Cutting-Edge Product Launches, and Anticipation for Key 2026 Conferences

Jia Lissa Apr 1, 2026 0

The biotechnology landscape has been particularly vibrant over the past two weeks, marked by a wave of strategic collaborations, significant…

Read More
Pharmaceutical R&D

The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet

Teuku Ryan Mar 26, 2026 0

On May 12, 2025, a significant executive order signed by then-US President Donald Trump mandated the US Department of Health…

Read More
Clinical Diagnostics & Pathology

CMS Launches Sweeping Anti-Fraud Initiative, Targeting Genetic Testing Spending and Soliciting Lab Industry Input for Future Regulations

Reynand Amr Wu Mar 26, 2026 0

The Centers for Medicare and Medicaid Services (CMS) has embarked on a significant preemptive strike against healthcare fraud, initiating a…

Read More
Pharmaceutical R&D

Excalipoint Therapeutics Launches with $68.7 Million Seed Funding to Advance Novel T-Cell Engager Pipeline

Teuku Ryan Mar 18, 2026 0

Chinese biotech startup Excalipoint Therapeutics has officially launched with a substantial $68.7 million in seed funding, positioning itself to accelerate…

Read More

Posts pagination

1 2
Science News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical LabsBeyond InheritanceScience News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ